Emselex

Emselex 7.5 and 15 mg prolonged-release tablets

QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 7.5 mg darifenacin (as hydrobromide).

PHARMACEUTICAL FORM
Prolonged-release tablet
White, round, convex tablet, with “DF” debossed on one side and “7.5/15” on the other.

Nature and contents of container
Transparent PVC / CTFE / aluminum or PVC / PVDC / aluminum pressure pack in carton containing 28 or 98 tablets.

For more information
SE: https://www.fass.se/LIF/startpage
NO: https://www.felleskatalogen.no
DK: http://www.produktresume.dk
FI: https://www.fimea.fi

Related Products

No results found.
×
Ingvar Bosaeus

Martin Björendahl

Marketing

Key Competence

21 years of experience in pharmaceuticals and medical technology, focused on sales and marketing, with an emphasis on product launches and contract negotiations.

Education

Degree in Marketing Economics from IHM, with certifications in pharmacology and leadership.

Experiences

Over 20 years of experience in sales and key accounts, focusing on product launches and specialist networks in neurology and women’s health.

×
Ingvar Bosaeus

Eirik Møglebust Larssen

Marketing

Key Competence

Specialist in the sale of pharmaceuticals and special products from the pharmaceutical industry. Extensive experience with drug launches. Sales and product presentations to medical departments/staff.

Education

Pharmaceutical Consultant in Medicine from University of Oslo.

Experiences
  • 25 years of experience in pharmaceuticals and medical technology, focused on sales and marketing, with an emphasis on product launches
×
Mats Erasmie

Mats Erasmie

Chairman of the board Simplex Motion AB. Consultant in Leadership and Business Development.

Key Competence

Sales, Leadership as a part of a strategic changes.

Education
  • MBA, International marketing, University of Stockholm
  • Certified in Authentic Leadership,Transaction Analysis, Situational Leadership (SL II, Blanchard).
  • Certified in Insight Discovery, Certified in DISC.
Experiences
  • Consultant in Leadership and Business Development.
  • Erasmie&Erasmie AB.
  • Chairman of the board Simplex Motion AB.
  • Consultant at Booster Group AB, business development and negotiations.'
  • Teacher at IHM, Market Analysis, Practical Marketing and Negotiations.
  • CEO, Chairman of the board and partner; Sällma AB.
  • Vice President Marketing & Sales, Consultant in Leadership and Business.
  • Development at Cordovan Performance Sweden AB.
  • CEO at Lucky Punk AB.
Publications

Books and training packages, marketing and sales, twelve in total since 1999

  • ”MED KUNDEN I FOKUS”, Liber Ekonomi 2000.
  • ”KUNDRELATIONEN”, Liber Ekonomi 2001.
  • ”FÖRSÄLJNING OCH SERVICE”, Liber Ekonomi 2003.
  • ”PERSONLIG FÖRSÄLJNING 1”, Liber Ekonomi 2012.
  • ”PERSONLIG FÖRSÄLJNING 2”, Liber Ekonomi 2014.
  • ”Dödskaravanen”, Historical novel, 2018.
  • ”Silverfloden”, Historical novel, 2019.
  • Various articles in the magazines Ledarskap, Affärsvärlden and Dagens Industri.

What Now?

You have defined your interest area and the questions related to this.

Now fill in the form and send it to us. The defined contact person from GHN Pharma Nordic will review your interest and contact you within 48 hours.

×

Get a Contact Person

×
Pontus Bergman

Valdet Hetemi

Head of Operation & Logistics

Key Competence

Over 17 years of experience within the Pharmaceutical industry; Rx, Medical Devices, Metabolic Diseases, OTC, Logistics and Supply Chain, Business Strategy, Finance, Sales and Marketing, Start-Ups.

Education
  • Education: Master of Business Administration and Bachelor of Social Sciences from the University of Lund and University of Cologne.
Experiences
  • Head of Operations at POA Pharma Scandinavia AB, Country Manager Sweden at Vitaflo Scandinavia AB/ Navamedic AB, Finance Manager at Vitaflo Scandinavia AB/Navamedic AB.
×
Ingvar Bosaeus

Martin Svahn

RP& Pharmacist

Key Competence

Martin Svahn is a licensed pharmacist and pharmacy manager.

Education
  • Licensed Pharmacist at University of Uppsala.
  • Magister thesis at the Departement of Anaesthesiology, University of Uppsala.
  • Master's Program in Clinical Pharmacy University of Uppsala.
Experiences
  • Start-up of a new privately owned pharmacy.
  • Worked in 2013 at K3 as GSST
  • Since 2014 pharmacy manager at three pharmacies with responsibility for 13-20 employees and an annual turnover of 80 million.
  • "Cluster manager" for Kronan's pharmacy Halland.
×
Mats Erasmie

Andreas Larsson

Finance Manager

Key Competence

Experience within the Pharmaceutical industry Rx, Medical Devices, Metabolic Diseases and OTC regarding Accounting and Finance Strategy, Financial reporting, Business Development and Logistical support

Education
  • Master of Aeronautical Science at the University of Embry-Riddle Aeronautical University and a degree at the KY academy of finance and accounting at Studium in Gothenburg.
Experiences
  • Accounting manager at POA Pharma Scandinavia AB, POA Pharma North America and Adrian & Partners AB.
×
Pontus Bergman

Pontus Bergman

PB Lawyer, founder of Bergman & Eek Advokat AB.

Key Competence

Principal fields of practice are strategically planning for privately owned companies regarding all legal and economic matters. Special focus on developing and establishing new companies or activities abroad, including international tax law for companies and employees.

 
Education
  • Education: Master of Laws from University of Lund
Experiences
  •  Partner at Setterwalls Law Firm.
  • Director of the board of POA Pharma AB and in several Swedish privately own companies.
×
Tina Madsen Sandström

Tina Madsen Sandström

Founder & CEO

Key Competence
Over 35 years experience within the international Pharmaceutical industry Rx, Medical Devices, OTC and Rare Metabolic Diseases, Administration, Leadership, Licenses & Acquisitions, Start-ups Development, Development, Management.
Education
Merkonom, Educated at Hillerød Business School. M
Experiences
  • Managing Director for Pharma-Vinci A/S, Member of the branch organisation BFID.
  • CEO Vitaflo Scandinavia AB.
  • CEO POA Pharma Scandinavia AB.
  • Director of the board Vitaflo Scandinavia AB.
  • Director of the board POA Consulting AB.
  • Director of the board POA Pharma Scandinavia AB.
×
Roland Sandström

Roland Sandström

Founder & Executive Chairman

Key Competence
45 years experience within the international Pharmaceutical industry; Rx, Medical Devices, Metabolic Diseases, OTC. Commercial Strategy, Business Development, License & Acquisitions, Start-ups Development, Management, Organisation Theory.
Education
Master of Political Science at the University of Lund.
Experiences
  • Managing Director Meda Sweden.
  • Board member of LSAB and LIF.
  • COB and Founder Vitaflo Scandinavia AB.
  • Director of the board Navamedic.
  • COB and Founder POA Pharma Scandinavia AB.
  • COB and Founder POA Pharma North America.
  • COB and Founder GHN Pharma International.
Publications
  • Kunden som Kompis (Customer as a Pal).
  • Articles around Project work, organisation theory and marketing.
  • Lectures and abstract publications at IPMA in Paris and Ljubljana.

The following sites is intended for healthcare professionals only

Are you a healthcare professional?